Glenmark Pharma makes entry into U.S. semisolid product market

March 17, 2008

Mumbai, India - Glenmark Pharmaceuticals, Inc., has begun U.S. marketing and distribution of five Clobetasol Propionate dermatology products, The Economy Times reports.

Mumbai, India

- A subsidiary of Glenmark Pharmaceuticals, Glenmark Pharmaceuticals, Inc., has begun marketing and distributing five Clobetasol Propionate dermatology products in the U.S., The Economy Times reports.

The products include cream, E-cream, ointment gel and topical solution and are being handled through a U.S.-based pharmaceutical development company, according to The Times.

The company plans to launch another 11 products throughout the course of a year.